Results 31 to 40 of about 35,233 (257)

Inhibitors in Patients with Congenital Bleeding Disorders Other Than Hemophilia [PDF]

open access: yes, 2017
The most worrying complication of replacement therapy for severe hemophilia A and B is currently the occurrence of inhibitory alloantibodies against infused factor VIII and factor IX, respectively.
Franchini, Massimo   +6 more
core   +1 more source

Assessment of Causes and Clinical Symptoms of Menorrhagia and Its Co-relation with BMI in Western Nepalese Women - An Observational Study [PDF]

open access: yesJournal of Krishna Institute of Medical Sciences University, 2017
Background: Menorrhagia is defined subjectively as heavy menses lasting for more than 7 days or objectively as a mean menstrual blood loss of >80 ml during three consecutive menses.
Farhat Banu   +3 more
doaj  

Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies [PDF]

open access: yes, 2016
A paucity of data exists on the incidence, diagnosis and treatment of bleeding in women with inherited factor VII (FVII ...
Batorova   +32 more
core   +2 more sources

Prevalence and determinants of dysmenorrhea: A cross-sectional study

open access: yesMRIMS Journal of Health Sciences, 2021
Background: Dysmenorrhea is a medical condition of pain during menstruation. A variety of factors effect dysmenorrhea which include early menarche, younger age, diet, prolonged and aberrant menstrual flow, psychological disturbances, and pelvic ...
D V B. Anusha   +3 more
doaj   +1 more source

Experience in the application of Ciklovita® vitamin-mineral complex in the treatment of menstrual irregularities [PDF]

open access: yesГинекология, 2017
A study of the effectiveness of the vitamin-mineral complex (VMC) Ciklovita in the complex treatment of menstrual irregularities was carried out on the basis of the SBIPH MR MRRIOG.
Yu M Belaya, V E Balan
doaj   +1 more source

Assessment of the menstrual problems among teenage girls: A tertiary care center study

open access: yesJournal of Pharmacy and Bioallied Sciences, 2023
Introduction: Due to shame over discussing menstruation and fear of illness, many adolescent girls with monthly problems never visit their family doctor or gynecologist. The presentation can be delayed as a result.
S Divya   +5 more
doaj   +1 more source

Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding. [PDF]

open access: yes, 2020
BackgroundThe levonorgestrel 52-mg intrauterine system has proven efficacy for heavy menstrual bleeding treatment in clinical trials, but few data exist to demonstrate how rapidly the effects occur and the effects in women with self-reported heavy ...
Chen, Beatrice A   +5 more
core  

Bleeding versus Clotting: A Complex Case of a Large Fibroid Uterus Causing Menorrhagia and a DVT

open access: yesCase Reports in Obstetrics and Gynecology, 2016
A 43-year-old woman presented with severe anaemia secondary to menorrhagia. Pelvic ultrasound showed a large intramural posterior fundal fibroid. Hysteroscopy showed the fibroid distorting the endometrial cavity, precluding Mirena® device insertion.
Sangeeta Ramanan   +2 more
semanticscholar   +1 more source

A comparative study between the efficacy of tranexamic acid and ibuprofen for treatment of menorrhagia induced by copper T-380A intrauterine device

open access: yesAl-Azhar Assiut Medical Journal, 2021
Background Menorrhagia is menstrual blood loss, which interferes with a woman’s physical, emotional, social, and material quality of life, and which can occur alone or in combination with other symptoms.
Mohamed Saad Shahin   +2 more
doaj   +1 more source

Successful treatment of refractory gastrointestinal bleeding by systemic (oral) ankaferd blood stopper in a patient with Glanzmann thrombasthenia [PDF]

open access: yes, 2015
Background: Glanzmann Thrombasthenia (GT) is a genetic platelet dysfunction and a life threatening disease. Ankaferd Blood Stopper (ABS) is a topical hemostatic agent of herbal origin which has been recently made available for clinical use.
Doğu, Mehmet Hilmi   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy